A framework for concurrent submission and review of oncology products

Source: www.fda.gov

Categories: Onc News and Journals, General Medicine News

Tweets with this article

FDA Oncology

OCE's Project Orbis posted the quarterly update of its approval list. FDA has approved 81 applications through Project Orbis since the project began in 2019. Click below 🔽 https://t.co/fiGFjKUo5T

ASTROgram for week of November 11 – American Society for Radiation Oncology (ASTRO)

ASTRO’s member newsletter for week of November 11: ROCR Act, 2025 QPP Final Rule, Seeking APEx Surveyors

ASTRO November 14, 2024

Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey

CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.

CA: A Cancer Journal for Clinicians November 14, 2024

Role of AI in Lysosomal Disorders: Big Data to Artificial Intelligence and Challenges

Learn about the role of AI in suspecting or diagnosing LDs.

CheckRare November 14, 2024

IASLC | International Association for the Study of Lung Cancer

The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and…

IASLC November 14, 2024

An Overview of FDA’s Project Facilitate Oncology Expanded Access Progr

On Tuesday, December 12, 2023, CDER’s Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: An Overview of…

FDA Oncology November 14, 2024